AR122136A1 - Apósito adhesivo medicamentoso de liberación lenta - Google Patents

Apósito adhesivo medicamentoso de liberación lenta

Info

Publication number
AR122136A1
AR122136A1 ARP210101380A ARP210101380A AR122136A1 AR 122136 A1 AR122136 A1 AR 122136A1 AR P210101380 A ARP210101380 A AR P210101380A AR P210101380 A ARP210101380 A AR P210101380A AR 122136 A1 AR122136 A1 AR 122136A1
Authority
AR
Argentina
Prior art keywords
adhesive dressing
medicated adhesive
slow release
release medicated
release
Prior art date
Application number
ARP210101380A
Other languages
English (en)
Inventor
Carlo Pizzocaro
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Publication of AR122136A1 publication Critical patent/AR122136A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Finger-Pressure Massage (AREA)

Abstract

Se describe un apósito adhesivo medicamentoso de liberación lenta a base de diclofenaco, específicamente un apósito adhesivo medicamentoso a base de sal de sodio de diclofenaco, cuya fórmula permite la liberación del principio activo de forma continua y en concentraciones terapéuticamente activas localmente durante 24 horas, y también una matriz adhesiva polimérica (PSA) para usar en un apósito adhesivo medicamentoso a base de sal de sodio de diclofenaco.
ARP210101380A 2020-05-20 2021-05-20 Apósito adhesivo medicamentoso de liberación lenta AR122136A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102020000011686A IT202000011686A1 (it) 2020-05-20 2020-05-20 Cerotto medicato a lento rilascio

Publications (1)

Publication Number Publication Date
AR122136A1 true AR122136A1 (es) 2022-08-17

Family

ID=71994907

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210101380A AR122136A1 (es) 2020-05-20 2021-05-20 Apósito adhesivo medicamentoso de liberación lenta

Country Status (35)

Country Link
US (1) US20230190668A1 (es)
EP (1) EP4153151B1 (es)
KR (1) KR20230013033A (es)
CN (1) CN115666537A (es)
AR (1) AR122136A1 (es)
AT (1) AT525409A3 (es)
BE (1) BE1028251B1 (es)
CA (1) CA3178964A1 (es)
CH (1) CH718822B1 (es)
CZ (1) CZ2022461A3 (es)
DE (1) DE112021002871T5 (es)
DK (2) DK4153151T3 (es)
EE (1) EE05862B1 (es)
ES (2) ES2936185R1 (es)
FI (1) FI4153151T3 (es)
FR (1) FR3110397A1 (es)
GB (1) GB2610106B (es)
GR (1) GR1010304B (es)
HR (1) HRP20240192T1 (es)
HU (2) HUP2200459A2 (es)
IE (1) IE20210109A1 (es)
IT (1) IT202000011686A1 (es)
LT (1) LT4153151T (es)
LU (1) LU501245B1 (es)
MA (1) MA59594B1 (es)
MD (1) MD4153151T2 (es)
NL (1) NL2028233B1 (es)
PL (2) PL245596B1 (es)
PT (1) PT4153151T (es)
RO (1) RO137440A2 (es)
RS (1) RS65194B1 (es)
SI (1) SI4153151T1 (es)
SK (1) SK500562022A3 (es)
TR (1) TR2021008324A2 (es)
WO (1) WO2021234562A1 (es)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09208463A (ja) * 1996-02-07 1997-08-12 Tsumura & Co 経皮吸収性に優れた消炎鎮痛組成物
JP4181232B2 (ja) * 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
JP4865958B2 (ja) * 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
CN1215838C (zh) * 2003-06-25 2005-08-24 蚌埠丰原医药科技发展有限公司 双氯芬酸钠贴剂及其制备方法
US20060078604A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
EP1877509B1 (en) 2005-03-17 2011-10-12 Pharmafilm S.R.L. An aqueous polymeric system for pressure sensitive adhesive matrix preparation
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
BR112013016998A2 (pt) 2010-12-29 2016-10-25 Pharmafilm S R L emplastro medicamentoso para a permeação transdérmica melhorada de diclofenaco dietilamônio
US20140100285A1 (en) * 2011-05-26 2014-04-10 Novartis Ag Compositions of percutaneous administration of physiologically active agents
PT2865378T (pt) * 2012-06-20 2018-01-15 Hisamitsu Pharmaceutical Co Adesivo para a pele
EP3206673B1 (en) 2014-10-17 2024-08-21 Fidia Farmaceutici S.p.A. Dermal therapeutic system with high adhesivity

Also Published As

Publication number Publication date
CH718822B1 (it) 2024-01-15
DE112021002871T5 (de) 2023-03-23
ES2936185A2 (es) 2023-03-14
CN115666537A (zh) 2023-01-31
GR20210100319A (el) 2021-12-09
RO137440A2 (ro) 2023-05-30
PL245596B1 (pl) 2024-09-02
CA3178964A1 (en) 2021-11-25
HRP20240192T1 (hr) 2024-05-10
EE05862B1 (et) 2024-01-15
GR1010304B (el) 2022-09-28
FR3110397A1 (fr) 2021-11-26
LU501245A1 (fr) 2022-02-15
GB2610106A (en) 2023-02-22
IT202000011686A1 (it) 2021-11-20
BE1028251A1 (fr) 2021-11-29
FI4153151T3 (fi) 2024-02-08
HUE066041T2 (hu) 2024-07-28
PL442805A1 (pl) 2023-07-03
PL4153151T3 (pl) 2024-04-22
AT525409A3 (de) 2023-04-15
NL2028233B1 (en) 2023-10-25
PT4153151T (pt) 2024-02-05
ES2972189T3 (es) 2024-06-11
NL2028233A (en) 2021-12-01
LT4153151T (lt) 2024-02-26
IE20210109A1 (en) 2022-08-17
GB2610106B (en) 2024-08-07
SK500562022A3 (sk) 2022-12-21
EP4153151A1 (en) 2023-03-29
EE202200014A (et) 2022-12-15
RS65194B1 (sr) 2024-03-29
MA59594B1 (fr) 2024-03-29
DK202201037A1 (en) 2022-11-21
KR20230013033A (ko) 2023-01-26
EP4153151B1 (en) 2023-11-22
TR2021008324A2 (tr) 2021-12-21
WO2021234562A1 (en) 2021-11-25
SI4153151T1 (sl) 2024-03-29
MD4153151T2 (ro) 2024-04-30
US20230190668A1 (en) 2023-06-22
ES2936185R1 (es) 2023-10-11
BE1028251B1 (fr) 2022-04-05
LU501245B1 (fr) 2022-05-17
DK4153151T3 (da) 2024-02-05
HUP2200459A2 (hu) 2023-03-28
GB202217015D0 (en) 2022-12-28
AT525409A2 (de) 2023-03-15
CZ2022461A3 (cs) 2022-12-14

Similar Documents

Publication Publication Date Title
ES2557303T3 (es) Agente terapéutico para la estenosis del canal espinal
DE602004019299D1 (de) Wundverbände für die kontrollierte freisetzung von therapeutischen mitteln
PE20130008A1 (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana
PE20061334A1 (es) Formas de dosificacion farmaceutica solidas administrables por via oral con liberacion modificada
RU2009147169A (ru) Новый агент для высвобождения активных веществ из повязок, содержащих по меньшей мере одно жировое вещество
RU2010128512A (ru) Гетероциклические ингибиторы мек и способы их применения
GT200200272A (es) Formas de sal e-2-metoxi-n-(3-{4-[3-metil-4-(6-metilpiridin-3-iloxi) fenilamino] quinazolin-6-il} alil)acetamidayprocedimiento para la produccion
UY27222A1 (es) Pirazolopirimidinas como agentes terapéuticos
UY27626A1 (es) Nuevos compuestos heterocíclos, activos como inhibidores de beta-lactamasas
CY1113670T1 (el) Φαρμακευτικη συνθεση για τη θεραπεια της υπερδραστηριας ουροδοχου κυστης
CY1106055T1 (el) Τυποποιηση των υποκατεστημενων βενζιμιδαζολων
AR063259A1 (es) Formas solidas de dosificacion farmaceuticas que comprenden compuestos microincluidos en polimeros ionicos insolubles en agua
AR029211A1 (es) Derivados de oxazoles, el uso de los mismos para la manufactura de un medicamento y composiciones farmaceuticas que los comprenden
RU2012124268A (ru) Бензимидазольные соединения и их применения
SE0401342D0 (sv) Therapeutic compounds
ECSP055583A (es) Compuestos del 1-fenil-2-dimetilamino-metil-ciclohexano, para la terapia de sintomatologia depresiva, dolor e incontinencia.
RU2014145270A (ru) Способ и композиция для разрушения бактериальной биопленки
CO6321285A2 (es) Uso de 3,11b-cis- dihidrotetrabenazina en el tratamiento de la esclerosis multiple y la mielitis autoinmunitaria
AR061166A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilferina
ATE331711T1 (de) Entzündungshemmende 3-arylthio-3- thiazolylalkylamine
ES2074191T3 (es) Oxazolidinonas.
AR029412A1 (es) Forma cristalina
AR122136A1 (es) Apósito adhesivo medicamentoso de liberación lenta
AR128761A1 (es) Compuesto heterocíclico para inducir la degradación de la proteína kras mutante en g12d
ECSP077843A (es) Tratamiento o prevención del prurito